Rational Vaccines

16 articles about Rational Vaccines

• Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Announce Collaboration to Develop Herpes Vaccines in China

  10/30/2023

  Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. announced they have reached an agreement to jointly develop, manufacture, and commercialize live vaccines against herpes simplex viruses.

• Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus

  8/15/2022

  Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the launch of a clinical trial designed to determine the baseline characteristics of patients diagnosed with recurrent symptomatic herpes simplex virus type 2 (HSV-2).

• 

  Rational's Experimental Herpes Vaccine Shows Preclinical Promise

  7/8/2022

  Rational Vaccines said findings from a pilot study showed that RVX201 led to a reduction in recurrent genital lesions when compared to gD2-alum/MPL vaccine in animal studies.

• Rational Vaccines' RVX1001 Vaccine Candidate Protects Against HSV Ocular Infection in vivo

  12/28/2021

  Rational Vaccines, today announced preclinical research suggesting that the Company's herpes simplex virus type 1 (HSV-1) vaccine candidate can protect against herpetic keratitis (HK), a leading infectious cause of blindness in developed countries.

• Rational Vaccines Announces a Clinical Study of the Frequency of Symptomatic Herpes Simplex Type 1 and 2 (HSV-1 and HSV-2) Virus in HIV Patients

  12/14/2021

  Rational Vaccines today announced the launch of a clinical trial designed to investigate the disease burden of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in patients with HIV infection.

• Rational Vaccines Announces the Appointment of Kerstin Westritschnig, MD, as Chief Medical Officer (CMO)

  9/15/2021

  Rational Vaccines today announced the appointment of Kerstin Westritschnig, MD, as the Company's chief medical officer (CMO).

• 

  A Rationally Designed Therapeutic Vaccine for Herpes

  7/26/2021

  A vaccine for herpes is under development and Rational Vaccines are going to make this a reality very soon. Here's everything you need to learn about it.

• Study validates pre-clinical safety of novel live-attenuated HSV-2 vaccine candidates

  3/30/2021

  Two novel vaccine candidates for the prevention and treatment of genital herpes have shown to be safe in pre-clinical animal studies according to a study published in the journal Vaccines.

• Leading Scientist Dr. Konstantin Kousoulas Shares His Mission to Eradicate Herpes

  3/1/2021

  By 1999 Dr. Konstantin 'Gus' Kousoulas was a tenured professor and consultant. While he wasn't extremely wealthy, he considered himself successful and satisfied with where life was going.

• Rational Vaccines believes live-attenuated virus vaccine development is the right approach

  12/8/2020

  Rational Vaccines, a vaccine biotech firm based in Cambridge, Mass., points to the proven science of live-attenuated viruses in vaccine development as key to the company's commitment to the development platform.

• Rational Vaccines announces launch of new website

  10/30/2020

  Rational Vaccines, a live-attenuated vaccine biotech firm based in Cambridge, Mass., announced the launch of its new website, https://rationalvaccines.com/.

• 

  FDA Launches Criminal Investigation into Rational Vaccines Over Unauthorized Herpes Research

  4/12/2018

  One month after three patients who developed adverse reactions following injections of an unauthorized herpes vaccine filed a lawsuit against Rational Vaccines, the U.S. Food and Drug Administration has launched a criminal investigation into the matter.

• Thiel-Backed Biotech Rational Vaccines Will Follow FDA Guidelines After Offshore Trial Controversy

  9/5/2017

• Cure For Herpes "On The Horizon," Rational Vaccines Reveals

  10/19/2016

• Rational Vaccines Release: First Ever Human Trial Of A Live Attenuated Functioning Therapeutic Herpes Vaccine

  10/17/2016

• Rational Vaccines Release: New Vaccine-Focused Company Aims To End Herpes

  9/26/2016